{"schema_version":"1","generated_at":"2026-11-05T16:53:10.908Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sayeh-lavasani","json_url":"https://www.findmykol.com/kol/sayeh-lavasani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sayeh-lavasani","name":"Sayeh Lavasani","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"City Of Hope National Medical Center","institution_url":"https://www.findmykol.com/institution/city-of-hope","city":"Orange","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1205130572","orcid":"0000-0002-3659-1960","openalex":"A5056788331"},"summary":"Sayeh Lavasani is an Oncology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 44 publications with 494 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":494,"h_index":11,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00003927","title":"Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT00003927","trial_url":"https://www.findmykol.com/trial/NCT00003927"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":26,"shown":3,"withheld":23,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":21940.03,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205130572"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":9620.18,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205130572"},{"payer":"AstraZeneca","program_year":2025,"amount_usd":7162.92,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205130572"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1205130572","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":88.8,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":74.4,"drugs":[{"name":"Anastrozole","share_pct":55.7},{"name":"Letrozole","share_pct":44.3}],"max_beneficiaries":38},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":14.3,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":12}]},{"area":"Nervous system","share_pct":11.2,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":11.2,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial","year":2026,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djag096","status":"verified"},{"title":"Abstract PS4-06-14: Tinengotinib in advanced or metastatic HR+/HER2- and TNBC: efficacy and biomarker correlative analysis from a phase Ib/II study","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-06-14","status":"verified"},{"title":"Abstract PS4-08-26: Weekly carboplatin and paclitaxel with trastuzumab and pertuzumab (HER2+) or bevacizumab (HER2-) in the neoadjuvant treatment of breast cancer: a phase II trial","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-08-26","status":"verified"},{"title":"Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-26-1076","status":"verified"},{"title":"Abstract 4352: Safety and pharmacokinetics of tinengotinib monotherapy in different doses and dosing schedules in advanced solid tumors","year":2025,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2025-4352","status":"verified"}],"source":"works"},"contact":{"address_1":"101 THE CITY DR S","city":"Orange","state":"CA","zip":"928683201","phone":"714-880-7812","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1205130572","source":"identity"},"similar":[{"name":"Erminia Massarelli","slug":"erminia-massarelli","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/erminia-massarelli","json_url":"https://www.findmykol.com/kol/erminia-massarelli/profile.json"},{"name":"Swetha Thiruvengadam","slug":"swetha-thiruvengadam","institution":"City Of Hope National Medical Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/swetha-thiruvengadam","json_url":"https://www.findmykol.com/kol/swetha-thiruvengadam/profile.json"},{"name":"Yuman Fong","slug":"yuman-fong","institution":"City Of Hope National Medical Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/yuman-fong","json_url":"https://www.findmykol.com/kol/yuman-fong/profile.json"},{"name":"Ravi Salgia","slug":"ravi-salgia","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ravi-salgia","json_url":"https://www.findmykol.com/kol/ravi-salgia/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":23,"publications":39}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-02-28","provider_certified":"2023-02-28","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}